Initial Thoughts on Vocabulary Testing for Meaningful Use Stage 2

Aug 26, 2012

110 likes | 239 Views

Discussion Topics. NIST's understanding of the request from the Vocabulary Task ForceMU requirements being discussedInput requested from NISTInitial thoughts on validating LOINC vocabulary requirementsthree requirements; will discuss each separately; will ask for clarifications and refinement of

Share Presentation

Embed Code

Link

savannah

Download Presentation

Initial Thoughts on Vocabulary Testing for Meaningful Use Stage 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Proposed Meaningful Use Criteria for Stage 2 and 3

Proposed Meaningful Use Criteria for Stage 2 and 3. Major Changes. All “Menu Set” criteria moved to Core Most performance percentages increase over time i.e. e-Prescribing 40% of orders in stage 1, 50% in stage 2, 80% in stage 3

220 views • 7 slides

Meaningful Use Workgroup Stage 3 Recommendations

Meaningful Use Workgroup Stage 3 Recommendations. Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co-Chair. Workgroup Membership. Co-Chairs: Paul Tang Palo Alto Medical Foundation George Hripcsak Columbia University Members:

258 views • 15 slides

Meaningful Use Stage 2

Meaningful Use Stage 2. The Changing Seasons of Healthcare Conference WV-HFMA/WV-HIMSS September 27, 2012. Agenda. Brief Overview of HIT Timeline and Stage 2 Timing Stage 2 Core Objectives Stage 2 Menu Items Changes to Stage 1 in Stage 2 Final Rule Summary of Stage 2 CQM & Reporting Q&A.

668 views • 43 slides

Meaningful Use Stage 2

Meaningful Use Stage 2. The Value of Performance Benchmarking. LEARNING OBJECTIVES. Understand how benchmarking leads to improvement Understand how analytics help meet MU stage 2 requirements. WHAT STAGE 2 MEANS TO YOU. Meaningful Use Stage 2 shifts from data capture to usability.

166 views • 0 slides

Meaningful Use - Stage 2

Meaningful Use - Stage 2. Prepared by: Health Technology Services Regional Extension Center A division of Mountain-Pacific Quality Health . Outline. MU Overview MU Stage 2 Final Rule Core/Menu Objectives Clinical Quality Measures Payment Adjustments. MU Overview. Rules.

150 views • 0 slides

Stage 2 Meaningful Use Presented by Becky Kane

Stage 2 Meaningful Use Presented by Becky Kane. Stage 2 Topics. Overview 2014 Reporting Changes Medicaid Provider Eligibility Core Objectives Comparison Menu Objectives Comparison Clinical Quality Measures. High Level Overview (1 of 2). Does everyone move to Stage 2 in 2014?

158 views • 0 slides

Meaningful Use Workgroup Meaningful Use Stage 3 Recommendations

Meaningful Use Workgroup Meaningful Use Stage 3 Recommendations. Paul Tang, chair George Hripcsak , co-chair. Meaningful Use Workgroup Membership. Paul Tang, Chair, Palo Alto Medical Center George Hripcsak , Co-Chair, Columbia University David Bates , Brigham & Women’s Hospital *

989 views • 77 slides

Meaningful Use Workgroup Pathways for Meaningful Use Stage 3

Meaningful Use Workgroup Pathways for Meaningful Use Stage 3 . Stages of Meaningful Use Improving Outcomes. Stage 3 2016-17. Stage 2 2014-15. Stage 1 2011-13. Original Principles for Stage 3 Recommendations.

388 views • 21 slides

Meaningful Use Stage 2 Security and Privacy Requirements

Meaningful Use Stage 2 Security and Privacy Requirements. Kathleen Connor VA (ESC) HL7 Security WG April 2012. Table of Contents. Presentation Purpose.

1.09k views • 99 slides

Recommendation to the Meaningful Use Workgroup on Meaningful Use Stage 3

Recommendation to the Meaningful Use Workgroup on Meaningful Use Stage 3. September 18, 2012 Information Exchange Workgroup Micky Tripathi, Larry Garber, Dave Goetz. Workgroup Membership. Micky Tripathi (Chair) Massachusetts eHealth Collaborative Hunt Blair Vermont Medicaid

371 views • 18 slides

Meaningful Use Workgroup New Pathways for Meaningful Use Stage 3

Meaningful Use Workgroup New Pathways for Meaningful Use Stage 3 . April 3, 2013 Paul Tang, MD George Hripcsak, MD Christine Bechtel. Stages of Meaningful Use Improving Outcomes. Stage 3 2016-17. Stage 2 2014-15. Stage 1 2011-13. Stages of Meaningful Use Improving Outcomes. Stage 3

429 views • 23 slides

Meaningful Use Workgroup New Pathways for Meaningful Use Stage 3

Meaningful Use Workgroup New Pathways for Meaningful Use Stage 3 . April 9, 2013 Paul Tang, MD George Hripcsak , MD Christine Bechtel. Agenda. Review of HITPC presentation and feedback Consolidation and Deeming Clinical Documentation

599 views • 44 slides

Meaningful Use Workgroup Meaningful Use Stage 3 Recommendations

Meaningful Use Workgroup Meaningful Use Stage 3 Recommendations. Paul Tang, chair George Hripcsak, co-chair. Meaningful Use Workgroup Membership. Paul Tang, Chair, Palo Alto Medical Center George Hripcsak, Co-Chair, Columbia University David Bates , Brigham & Women’s Hospital *

936 views • 77 slides

A First Look at Meaningful Use Stage 2

A First Look at Meaningful Use Stage 2. John D. Halamka MD. Overall requirements. EPs must meet or qualify for an exclusion to 17 core objectives and 3 of 5 menu objectives. (Stage 1 was 15/5 of 10)

239 views • 15 slides

ARRA Stage 1 Meaningful Use

ARRA Stage 1 Meaningful Use . Journey to Attestation. Pamela Feeler, RNC Director of Nursing Informatics, PCRMC. Phelps County Regional Medical Center. 235 Licensed Beds MEDITECH MAGIC 5.64 Located in Rolla, Missouri Approx 100 miles between St. Louis and Springfield. History. 2001

414 views • 30 slides

Meaningful Use Stage I Class II

Meaningful Use Stage I Class II. Clinical Quality Measures Shannon Earhart, RRT Sr. Analyst AHIS. OBJ-304J Calculate and transmit CMS quality measures. Providers must report to CMS or their state At least six Clinical Quality Measures Including 3 Core Measures 3 Additional Measures.

403 views • 24 slides

Meaningful Use Stage 2 JoAnne Hawkins OIT Meaningful Use Team Lead

Barcode Medication Administration Awareness R esource P atient M anagement S ystem. Meaningful Use Stage 2 JoAnne Hawkins OIT Meaningful Use Team Lead. Objectives. Examine the Meaningful Use Proposed Stage 2 Medication Administration Tracking Objective. Stage 1 Performance Measures.

275 views • 9 slides

Proposed Meaningful Use Criteria for Stage 2 and 3

Proposed Meaningful Use Criteria for Stage 2 and 3. John D. Halamka. Major Changes. All “Menu Set” criteria moved to Core Most performance percentages increase over time i.e. e-Prescribing 40% of orders in stage 1, 50% in stage 2, 80% in stage 3

208 views • 7 slides

Meaningful Use Stage 2 = Value Based Purchasing

Meaningful Use Stage 2 = Value Based Purchasing. Michele P. Madison mmadison@mmmlaw.com 404-504-7621. Value Based Purchasing. Linking provider payments to improved performance by health care providers.

686 views • 32 slides

Meaningful Use (MU): Stage 2 and 2014 Changes

Meaningful Use (MU): Stage 2 and 2014 Changes. Shannon Means, MPA Health Informatics Specialist II Health Services Advisory Group of California, Inc. (HSAG of California). HSAG of California. Quality Improvement Organization for Arizona, California, and Florida

420 views • 28 slides

Initial thoughts....

A very quick gallop thro’ approaches to data collection and evaluation that will help you design and then justify your work Mic Porter (Aged 3½). Initial thoughts. Define acceptable and unacceptable performance/decide upon standards and agree expectations.

600 views • 46 slides

Meaningful Use Workgroup New Pathways for Meaningful Use Stage 3

Meaningful Use Workgroup New Pathways for Meaningful Use Stage 3. April 9, 2013 Paul Tang, MD George Hripcsak , MD Christine Bechtel. Agenda. Review of HITPC presentation and feedback Consolidation and Deeming Clinical Documentation

593 views • 44 slides

More Related